1 active not recruiting, 1 not yet recruiting, 1 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Interval debulking surgery: new trials by email Literature Review of Interval debulking surgery trials Research Report on Interval debulking surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PDS Versus NACT-IDS in AI-Selected Advanced Epithelial Ovarian Cancer Upfront cytoreductive surgery, Interval debulking surgery, Platinum-based chemotherapy - Epithelial Ovarian Cancer, Fallopian Tube Cancers | Phase 2 / Phase 3 | Not yet recruiting | Shanghai Gynecologic Oncology Group | 534 | 2026-12-31 | 2026-11-12 |
| Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer Hyperthermic Intraperitoneal Chemotherapy, Interval debulking surgery, neoadjuvant chemotherapy - Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Unknown | Shu-Zhong Cui | 263 | 2018-03-01 | 2018-01-24 |
| Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) Upfront cytoreductive surgery, Interval debulking surgery - Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Active not recruiting | Shanghai Gynecologic Oncology Group | 489 | 2016-08-01 | 2025-02-10 |
Carcinoma, Ovarian Epithelial (3) · Fallopian Tube Neoplasms (3)
Shanghai Gynecologic Oncology Group (2) · Shu-Zhong Cui (1)
China (3) · South Korea (1)
Rongyu Zang, MD,PHD (1) · Shuzhong Cui, M.D (1) · Zhongqiu Lin, M.D (1)